Home > Insider Trading > Filing (0000904454-18-000629)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1526119	Verastem Inc.	VSTM	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1319890	Robert Forrester	C/O Verastem, Inc. 117 Kendrick Street, Suite 500 Needham MA 02494	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-09-28	2,000	$7.00	221,234	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2018-09-24	60,000	$0.00	60,000	$2.97

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
60,000	2018-09-24	2028-01-05	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,000	Indirect	By trust
Common Stock	5,000	Indirect	By trust

Footnotes

Shares held by The Claudia Forrester 2001 Trust, the beneficiary of which is Claudia Forrester, the Reporting Person's daughter. The Reporting Person is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Shares held by The Iona Forrester 2001 Trust, the beneficiary of which is Iona Forrester, the Reporting Person's daughter. The Reporting Person is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
On January 5, 2018, the Reporting Person was granted an option to purchase 150,000 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance milestones by June 30, 2018, by March 31, 2019, and within the first twenty-four (24) months after the achievement of certain net sales targets. 20% of the performance criteria was met on April 6, 2018, resulting in vesting of the option as to 30,000 shares. 40% of the performance criteria was met on September 24, 2018, resulting in vesting of the option as to 60,000 shares.